Skip to content
Riskpilot
← Back to search
Sign in
Get full access
QuantumCell ApS
APS
Active
Advertising protection
CVR 45663205
Nordre Fasanvej 215, 2000
Frederiksberg
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2025 · 1 year old
4 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
QuantumCell ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MK
Mads Kristian Dalsgaard
Chief Executive Officer
Chief Executive Officer
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
KL
Kasper Lage Hansen
Board of Directors
2025
CE
Christian Ellebæk Elling
Board of Directors
2025
MB
Marco Boorsma
Board of Directors
2025
MK
Manish Kothari
Board of Directors
2025
PF
Peter Finsel Bisgaard
Chairman
2025
SM
Søren Møller
Board of Directors
2025
Former (2)
PH
Peter Høngård Andersen
Board of Directors
2025 – 2025
AG
Anta Gkelou
Board of Directors
2025 – 2026
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Novo Holdings A/S
Company
15–19.99%
15–19.99%
2025
Forbion Ventures Fund VII
Individual
15–19.99%
15–19.99%
2025
Sofinnova Capital XI SCSp SICAV-RAIF
Individual
10–14.99%
10–14.99%
2025
First Spark Venture Fund, L.P.
Individual
10–14.99%
10–14.99%
2025
LUNDBECKFOND INVEST A/S
Company
10–14.99%
10–14.99%
2025
BHNS Holding ApS
Company
5–9.99%
5–9.99%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on QuantumCell ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network